PSMB5 and Miyoshi myopathy: Previous studies have shown that heat shock protein 27 (26,27) and proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein decrease sensitivity to bortezomib in MM and myelomonocytic THP1 cells, respectively (28).